CatalystWireBeta

Total Voting Rights

In brief · summary, not quotable

SkinBioTherapeutics plc has announced an update to its total voting rights, stating that following the admission of 129,736 new ordinary shares to satisfy share option exercises, the company now has 258,909,199 Ordinary Shares in issue. This updated figure of 258,909,199 will serve as the denominator for shareholders determining their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes

Following the admission today of 129,736 new ordinary shares of 1 pence each to satisfy the exercise of share options, the Company has 258,909,199 Ordinary Shares in issue. This figure of 258,909,199 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note